VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 3, 2026
Stock Comparison
Keyence Corporation vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Keyence Corporation
6861.T · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Keyence Corporation's moat claims, evidence, and risks.
View 6861.T analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Keyence Corporation leads (73 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Keyence Corporation has 3 segments; Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: Keyence Corporation has 7 moat types across 2 domains; Amgen Inc. has 5 across 3.
Primary market context
Keyence Corporation
Sensors & Safety/Static Control
Industrial sensors and safety/static control for factory automation
Global
Manufacturers (production/automation teams) and machine builders
Component OEM and application-solution provider
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
Keyence Corporation strengths
Amgen Inc. strengths
Segment mix
Keyence Corporation segments
Full profile >Sensors & Safety/Static Control
Oligopoly
Machine Vision, Code Reading & Laser Marking
Oligopoly
Metrology & Microscopes
Oligopoly
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.